Product Information
INPEFA 200 MG TABLET is a brand product labeled by Lexicon Pharmaceuticals, Inc., priced at $20.4601 per EA under NDC 70183022131. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on May 26, 2023.
Strength
200 mg/1
Manufacturer
Lexicon Pharmaceuticals, Inc.NDC
70183022131
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SOTAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA216203FDA Approved
5/26/2023
On Market Since
5/26/2023
Pharmacological Classes
Price Statistics
The NADAC for INPEFA 200 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.4601 per EA |
|---|---|
| All-time high | $20.4998 (Aug 12, 2026) |
| All-time low | $19.1726 (Apr 17, 2024) |
| 52-week high | $20.4998 |
| 52-week low | $19.7207 |
| Median price | $19.7358 |
| Average price | $19.8533 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INPEFA 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INPEFA 200 MG TABLET, manufactured by Lexicon Pharmaceuticals, Inc., is $20.4601 per EA (NDC 70183022131), effective Aug 19, 2026.
How has the price of INPEFA 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for INPEFA 200 MG TABLET has risen 6.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for INPEFA 200 MG TABLET?
Since Apr 17, 2024, the NADAC for INPEFA 200 MG TABLET has ranged from a low of $19.1726 (Apr 17, 2024) to a high of $20.4998 (Aug 12, 2026), with a median of $19.7358 per EA.
Are there cheaper alternatives to INPEFA 200 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INPEFA 200 MG TABLET, is $19.7358 per EA — about 4% below INPEFA 200 MG TABLET.
Who manufactures INPEFA 200 MG TABLET?
INPEFA 200 MG TABLET (NDC 70183022131) is labeled by Lexicon Pharmaceuticals, Inc., and CMS classifies it as a brand product.